Literature DB >> 12074906

Direct, real-time assessment of dopamine release autoinhibition in the rat caudate-putamen.

T H Lee1, K R Gee, C Davidson, E H Ellinwood.   

Abstract

Inhibition of endogenous dopamine release by photo-released dopamine (i.e., autoinhibition) was characterized in the rat caudate-putamen using combined caged-dopamine photolysis and fast-scan cyclic voltammetry. Coronal brain slices (400 microm thick) were perfused with caged-dopamine (150-200 microM in artificial cerebrospinal fluid). Ultraviolet illumination of increasing duration (25-250 ms, approximately 100 microm beam diameter) was focused at the tip of the recording electrode to uncage increasing amounts of exogenous dopamine at the recording sites (0.5-5 microM); a single biphasic electrical stimulus was delivered 0.1-10 s later to induce endogenous dopamine release. The concentrations of both endogenous and exogenous dopamine were determined using voltammetry, thus enabling determination of concentration-dependent inhibition of the endogenous release by the latter. While unaffected by control ultraviolet illumination, endogenous dopamine release was rapidly inhibited by photo-released dopamine in a concentration-dependent manner. Photo-application of 3-5 microM exogenous dopamine inhibited the endogenous release by 90-100% (electrical stimulus applied 1 s after photolysis initiation), an effect prevented by 2 microM sulpiride. The autoinhibition was dependent on the time between photolysis onset and electrical stimulation. Terminal dopamine autoreceptor stimulation led to robust inhibition of endogenous dopamine release with a latency of approximately 200 ms and effective duration of less than 5 s. The percent autoinhibition was a skewed, U-shaped function of photolysis/electrical stimulation intervals with the peak inhibition at 1 s. This study directly demonstrates that autoreceptor-mediated inhibition of terminal dopamine release in caudate-putamen is designed to provide a rapid, robust, yet short-lasting modulation of terminal dopamine release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074906     DOI: 10.1016/s0306-4522(02)00102-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons.

Authors:  Cedric Yapo; Anu G Nair; Lorna Clement; Liliana R Castro; Jeanette Hellgren Kotaleski; Pierre Vincent
Journal:  J Physiol       Date:  2017-09-02       Impact factor: 5.182

2.  Subsecond regulation of striatal dopamine release by pre-synaptic KATP channels.

Authors:  Jyoti C Patel; Paul Witkovsky; William A Coetzee; Margaret E Rice
Journal:  J Neurochem       Date:  2011-08-04       Impact factor: 5.372

3.  Glutamate and dopamine transmission from midbrain dopamine neurons share similar release properties but are differentially affected by cocaine.

Authors:  Martín F Adrover; Jung Hoon Shin; Veronica A Alvarez
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

Review 4.  Dopamine release in the basal ganglia.

Authors:  M E Rice; J C Patel; S J Cragg
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

5.  Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter-In Silico and In Vitro Exploration of Dissociative Diarylethylamines.

Authors:  Michelle A Sahai; Colin Davidson; Neelakshi Dutta; Jolanta Opacka-Juffry
Journal:  Brain Sci       Date:  2018-04-07

6.  In Vitro Neurochemical Assessment of Methylphenidate and Its "Legal High" Analogs 3,4-CTMP and Ethylphenidate in Rat Nucleus Accumbens and Bed Nucleus of the Stria Terminalis.

Authors:  Colin Davidson; Christopher A R Raby; Vincenzo Barrese; John Ramsey
Journal:  Front Psychiatry       Date:  2018-05-28       Impact factor: 4.157

7.  Structure-based development of caged dopamine D2/D3 receptor antagonists.

Authors:  Marie Gienger; Harald Hübner; Stefan Löber; Burkhard König; Peter Gmeiner
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.